FDA-Inspected Site

Syngene USA Inc.

3 FDA inspections are on record for Syngene USA Inc. in Baltimore, United States.

Clean· No action indicated

Baltimore, United States · Last updated July 11, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-02-08.

At a glance

Inspections

3

Form 483s

2

EIRs

3

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
8 Feb 2024BiologicsClean
12 Apr 2021 – 20 Apr 2021Biologics483On file
9 Apr 2020 – 20 Apr 2020Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

20 Apr 2020
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Marcellinus D Dordunoo

20 Apr 2020
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Marcellinus D Dordunoo

20 Apr 2020
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Marcellinus D Dordunoo

20 Apr 2020
21 CFR 211.42(c)(2)

Rejected Material Area

Cited by Marcellinus D Dordunoo

20 Apr 2020
21 CFR 211.68(b)

Computer control of master formula records

Cited by Marcellinus D Dordunoo

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Syngene USA Inc.'s 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat